This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

De Gramont Regimen

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What the De Gramont Regimen Means

The De Gramont regimen is a chemotherapy treatment that uses two main drugs: fluorouracil (often called 5-FU) and folinic acid (also known as leucovorin). These drugs work together to help stop cancer cells from growing and dividing. This regimen is most often used to treat colorectal cancer, which affects the colon or rectum. It can also be part of treatment plans for cancers of the esophagus or stomach, sometimes combined with radiation therapy.

Why It Can Matter in Cancer Care

This chemotherapy combination is important because it offers a way to control cancer growth. In some cases, doctors add another drug called oxaliplatin to create a regimen known as FOLFOX. Studies have shown that adding oxaliplatin may help delay cancer progression, meaning the cancer stays under control longer. However, it does not always increase the overall length of survival. Understanding these benefits and limits helps patients and caregivers make informed decisions about treatment options.

What Patients Might See or Experience

If you hear the term De Gramont regimen, it may come up in your treatment plan, medical reports, or discussions with your care team. The treatment involves receiving chemotherapy drugs through an infusion, usually into a vein. Side effects can include feeling tired, nausea, diarrhea, low blood counts, and numbness or tingling in the hands and feet. Some patients may experience allergic reactions, especially to platinum-based drugs like oxaliplatin if it is part of the regimen. These side effects can affect daily life and should be discussed with your healthcare providers.

Where the Term Might Appear

You might see the De Gramont regimen mentioned in your medical records, chemotherapy orders, or clinical trial descriptions. It may also appear in drug information sheets or educational materials about colorectal cancer treatment. Because it is part of a broader set of chemotherapy options, it’s helpful to understand how it fits with other treatments like FOLFOX or CAPOX, which include additional drugs.

What the Term Does Not Automatically Mean

Hearing the term De Gramont regimen does not mean a specific diagnosis or guarantee a particular outcome. It is a name for a chemotherapy combination, not a cancer type or stage. Also, it does not mean the treatment will cure cancer or extend life in every case. Treatment plans are personalized, so the presence of this term should prompt questions about how it applies to your unique situation.

Practical Questions to Ask Your Care Team

When the De Gramont regimen is mentioned, you might ask: How does this treatment fit my cancer type and stage? What benefits can I expect? What side effects should I watch for? How will this treatment be given? Are there other treatment options? Understanding these details can help you feel more confident and involved in your care.

How to Read the Term in Context

Always consider the De Gramont regimen as part of a larger treatment plan. It’s best to ask your care team what it means in your specific case rather than relying on the term alone. Treatment names can sound technical, but their meaning depends on how they are used for each patient.

Safety and Next Steps

This information is educational and does not replace medical advice. If you see the term De Gramont regimen in your records or hear it from your care team, the safest next step is to ask them directly what it means for you. They can explain how this treatment fits your diagnosis, what to expect, and how to manage side effects. Being informed helps you participate actively in your cancer care.

Sources

Public source information used for this glossary entry includes: